Jove
Visualize
Contact Us

Related Concept Videos

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
What is the Immune System?01:38

What is the Immune System?

127.1K
Overview
127.1K
Cancer Vaccines01:30

Cancer Vaccines

984
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
984
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K
Active versus Passive Immunity01:31

Active versus Passive Immunity

10.1K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
10.1K
Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human <i>Staphylococcus aureus</i> Bacteremia.

Antibiotics (Basel, Switzerland)·2026
Same author

Editorial for the Special Issue "Staphylococcal Biology and Pathogenesis".

Antibiotics (Basel, Switzerland)·2026
Same author

Prophage-encoded virulence factor, Gp05, contributes to endothelial cell dysfunction and immune evasion to promote persistent methicillin-resistant <i>Staphylococcus aureus</i> endovascular infections.

mBio·2025
Same author

Genetic Correlates of Synergy Mechanisms of Daptomycin Plus Fosfomycin in Daptomycin-Susceptible and -Resistant Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA).

Microorganisms·2025
Same author

The lack of a biorepository during vaccine trials: A lost opportunity to understand staphylococcal immunity.

Vaccine·2025
Same author

Bicarbonate Within: A Hidden Modulator of Antibiotic Susceptibility.

Antibiotics (Basel, Switzerland)·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 22, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.2K

Immunity to Staphylococcus aureus: Implications for Vaccine Development.

Richard A Proctor1

  • 1University of Wisconsin, Medical Microbiology/Immunology, Madison, WI 53705.

Microbiology Spectrum
|July 13, 2019
PubMed
Summary

Cell-mediated immunity is key for invasive Staphylococcus aureus infections, but its imbalance causes severe disease. Targeting superantigens with monoclonal antibodies may improve immune responses and vaccine safety.

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.3K
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
09:15

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

Published on: February 28, 2019

13.2K

Related Experiment Videos

Last Updated: Jan 22, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.2K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.3K
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
09:15

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

Published on: February 28, 2019

13.2K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Cell-mediated immunity is crucial for controlling invasive Staphylococcus aureus infections.
  • Immune dysregulation, including imbalances in T cell responses, contributes to severe disease and mortality.
  • Anti-toxin antibodies may mitigate Staphylococcus aureus infection severity and superantigen-induced immune issues.

Purpose of the Study:

  • To explore the dual role of cell-mediated immunity in Staphylococcus aureus infections.
  • To investigate the potential of targeting superantigens for therapeutic intervention.
  • To examine hypotheses for improving immune responses and safety of Staphylococcus aureus vaccines.

Main Methods:

  • Hypothetical modeling of immune responses to Staphylococcus aureus.
  • Analysis of the role of T cell responses and anti-toxin antibodies.
  • Consideration of monoclonal antibody therapies against superantigens.

Main Results:

  • Immune dysregulation is implicated as a primary driver of mortality in severe Staphylococcus aureus infections.
  • Therapeutic strategies targeting T cell responses may be challenging.
  • Monoclonal antibodies against superantigens show promise for managing dysfunctional immune responses.

Conclusions:

  • Dysregulated cell-mediated immunity significantly impacts Staphylococcus aureus infection outcomes.
  • Monoclonal antibodies targeting superantigens represent a potential therapeutic avenue.
  • Further research into these models could enhance Staphylococcus aureus vaccine efficacy and safety.